Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by langostaon May 02, 2022 6:14pm
189 Views
Post# 34649324

Does this sound vaguely familiar?

Does this sound vaguely familiar?

COLLEGE STATION, Texas — Treatment for colorectal cancer usually means surgery, often accompanied by chemotherapy. Both types of treatment carry risks, including residual disease and toxic side effects. A newer, safer treatment is in development by Dr. Sung II Park and his team at Texas A&M University. It consists of a low cost, minimally invasive, wireless device that provides precise colorectal cancer treatment.  

How does the innovative technique work? Surgeons will remove the bulk of a tumor. Then, using a photosensitizing drug activated by light, they will irradiate the tumor bed to kill residual colorectal cancer cells.

“The biocompatible, miniaturized, implantable LED device will facilitate photodynamic therapy (PDT) that is tailored to the individual tumor response,” says Park, an assistant professor in the Department of Electrical and Computer Engineering at the university, in a statement.

The system has the potential to provide remote, continuous health monitoring. It may also prevent recurrence, significantly improving the quality of life for people with cancers. This method of disease management would reduce the enormous economic burden of oncology-related expenditures, totaling $167 billion U.S. dollars in 2020. A 23.35 percent increase is projected for 2022.

<< Previous
Bullboard Posts
Next >>